Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 22 | 21776836 | intron variant | T/G | snv | 0.54 |
|
Immune System Diseases; Nervous System Diseases | 0.800 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms | 0.710 | 1.000 | 2 | 2015 | 2016 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
22 | 21835874 | intron variant | C/A | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.776 | 0.160 | 22 | 21772875 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 22 | 21855846 | intron variant | A/C | snv | 0.34 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 22 | 21761597 | 3 prime UTR variant | C/T | snv | 0.16 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 22 | 21769233 | missense variant | C/A;T | snv | 4.0E-06; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 22 | 21769233 | missense variant | C/A;T | snv | 4.0E-06; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 22 | 21767265 | intron variant | T/C;G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.120 | 22 | 21792110 | intron variant | A/G | snv | 0.54 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 22 | 21833371 | intron variant | A/C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.080 | 22 | 21833371 | intron variant | A/C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.080 | 22 | 21833371 | intron variant | A/C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.080 | 22 | 21760715 | 3 prime UTR variant | C/G | snv | 0.49 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 22 | 21760715 | 3 prime UTR variant | C/G | snv | 0.49 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.080 | 22 | 21850504 | intron variant | G/A | snv | 0.55 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.080 | 22 | 21850504 | intron variant | G/A | snv | 0.55 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 |